The University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

Press/Media: Press / Media

PeriodMar 26 2021

Media coverage

1

Media coverage

  • TitleThe University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
    Media name/outletIndia Pharma News
    CountryIndia
    Date3/26/21
    PersonsKumar Sharma